Founded:
2007
Address:
Auspex Pharmaceuticals Inc
1261 Liberty Way
Suite C
92081-8356
Vista
, California
United States
Phone:
(760) 599-1800
See map: Google Maps
California US
Auspex Pharmaceuticals Inc
3366 N Torrey Pines Court
Suite 225
92037
La Jolla
, California
United States
Phone:
(858) 558-2400
See map: Google Maps
California US
Web site:
http://www.auspexpharma.comFunding history
Series C | (Oct 2010) |
| Investor | Profile | Country | Industry | Notes | ||
|---|---|---|---|---|---|---|
|
CMEA Capital (CMEA Ventures), (Chemical and Materials Enterprise Associates) |
United States | 6630 Fund management | edit | |||
|
Sloan Ventures LLC |
United States | edit | ||||
|
Thomas McNerney & Partners LLC |
Healthcare venture firm. | United States | 6630 Fund management | edit |
Series B | (May 2008) |
| Investor | Profile | Country | Industry | Notes | ||
|---|---|---|---|---|---|---|
|
CMEA Capital (CMEA Ventures), (Chemical and Materials Enterprise Associates) |
United States | 6630 Fund management | edit | |||
|
Thomas McNerney & Partners LLC |
Healthcare venture firm. | United States | 6630 Fund management | edit |
Add a funding round.
SEC Filings
6 Sep 2013 Form D/A
Industry group:
- Health Care
- Pharmaceuticals
Date of first sale: 31 Oct 2012
Offering amount: USD 27,992,742
Amount sold: USD 27,992,742
Number of investors: 9
Remaining to be sold: USD 0
Minimum investment accepted: USD 0
Sales commissions: USD 0
Finders' fees: USD 0
Use of proceeds: USD 0
9 Nov 2012 Form D
Industry group:
- Health Care
- Pharmaceuticals
Date of first sale: 31 Oct 2012
Offering amount: USD 25,492,741
Amount sold: USD 17,492,739
Number of investors: 8
Remaining to be sold: USD 8,000,002
Minimum investment accepted: USD 0
Sales commissions: USD 0
Finders' fees: USD 0
Use of proceeds: USD 0
31 Jul 2012 Form D
Industry group:
- Health Care
- Pharmaceuticals
Date of first sale: 18 Jul 2012
Offering amount: USD 3,000,000
Amount sold: USD 1,500,000
Number of investors: 5
Remaining to be sold: USD 1,500,000
Minimum investment accepted: USD 0
Sales commissions: USD 0
Finders' fees: USD 0
Use of proceeds: USD 0
Warrants for the purchase of Preferred Stock were issued in connection with the Offering for no additional consideration. The aggregate number of warrant shares is contingent on a formula set forth in each of the warrants.
28 Dec 2011 Form D
Industry group:
- Health Care
- Pharmaceuticals
Date of first sale: 15 Dec 2011
Offering amount: USD 6,000,000
Amount sold: USD 3,000,000
Number of investors: 7
Remaining to be sold: USD 3,000,000
Minimum investment accepted: USD 0
Sales commissions: USD 0
Finders' fees: USD 0
Use of proceeds: USD 0
Warrants for the purchase of Pref Stock were issued at the Offering. No additional consideration was received for the Warrants. The # of warrant shares issuable upon exercise of the Warrants is contingent upon a formula set forth in each of the Warrants.
26 Jul 2010 Form D
Industry group:
- Health Care
- Pharmaceuticals
Date of first sale: 15 Jun 2007
Offering amount: USD 13,825,000
Amount sold: USD 13,825,000
Number of investors: 5
Remaining to be sold: USD 0
Minimum investment accepted: USD 0
Sales commissions: USD 0
Finders' fees: USD 0
Use of proceeds: USD 0
12 Jul 2010 Form D
Industry group:
- Health Care
- Pharmaceuticals
Date of first sale: 2 Jul 2010
Offering amount: USD 11,999,999
Amount sold: USD 11,999,999
Number of investors: 8
Remaining to be sold: USD 0
Minimum investment accepted: USD 0
Sales commissions: USD 0
Finders' fees: USD 0
Use of proceeds: USD 0
26 Feb 2010 Form D
Industry group:
- Health Care
- Pharmaceuticals
Date of first sale: 8 Jan 2010
Offering amount: USD 2,000,000
Amount sold: USD 2,000,000
Number of investors: 6
Remaining to be sold: USD 0
Minimum investment accepted: USD 0
Sales commissions: USD 0
Finders' fees: USD 0
Use of proceeds: USD 0
No additional consideration was received for the issuance of the warrants. The aggregate number of warrant shares issuable upon exercise of the warrants is contingent upon a formula set forth in each of the warrants.
22 Oct 2009 Form D
Industry group:
- Health Care
- Pharmaceuticals
Date of first sale: 9 Oct 2009
Offering amount: USD 2,000,000
Amount sold: USD 2,000,000
Number of investors: 5
Remaining to be sold: USD 0
Minimum investment accepted: USD 0
Sales commissions: USD 0
Finders' fees: USD 0
Use of proceeds: USD 0
No additional consideration was received for the issuance of the warrants. The aggregate number of warrant shares issuable upon exercise of the warrants is contingent upon a formula set forth in each of the warrants.
3 Aug 2009 Form D
Industry group:
- Health Care
- Pharmaceuticals
Date of first sale: 22 May 2009
Offering amount: USD 3,000,000
Amount sold: USD 3,000,000
Number of investors: 7
Remaining to be sold: USD 0
Minimum investment accepted: USD 0
Sales commissions: USD 0
Finders' fees: USD 0
Use of proceeds: USD 0
Insights:
PSEPS ID: 448818
External Links
